Rachel Moszyk

Research Scientist at Iaso Therapeutics

Dr. Rachel Moszyk is Iaso’s Biology Research Scientist. Dr. Moszyk has expertise in life science, immunology and biology. She is excited to continue the work of translating the mQb bacteriophage platform into novel vaccines.

Dr. Moszyk received her B.Sc. in Cellular and Molecular Biology from the University of Michigan. She then went on to complete her Ph.D. from Washington University in St. Louis in Jeffrey Bednarski’s Laboratory studying the role of the DNA damage response in developing B cells.

Peers

View in org chart

Timeline

  • Research Scientist

    Current role